1,3-dipropyl-8-(4-sulfophenyl)xanthine has been researched along with losartan in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albino-Teixeira, A; GuimarĂ£es, S; Morato, M; Moura, D; Sousa, T | 1 |
1 other study(ies) available for 1,3-dipropyl-8-(4-sulfophenyl)xanthine and losartan
Article | Year |
---|---|
Losartan and atenolol on hypertension induced by adenosine receptor blockade.
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Angiotensin II Type 2 Receptor Blockers; Animals; Atenolol; Cell Division; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Hypertension; Infusion Pumps, Implantable; Infusions, Parenteral; Losartan; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Myocardium; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Receptors, Adrenergic, beta-1; Receptors, Purinergic P1; Renin; Tail; Xanthines | 2003 |